IDiyas

For the Inventor, By the Inventor

Leverkusen, Germany

Volker-Bernd Fiedler

USPTO Granted Patents = 21

Average Co-Inventor Count = 6.6

ph-index = 6

Forward Citations = 118(Granted Patents)


Company Filing History:

goldMedal21 out of 12,157 
 
Bayer Aktiengesellschaft
 patents

Years Active: 1988-1996

Loading Chart...
21 patents (USPTO):Explore Patents
1. 5565561 - Natural substance cyclamenol and chemical derivatives (1996-10-15),
2. 5374647 - Antithrombotic substituted cycloalkano (B) dihydroindole sulphonamides (1994-12-20),
3. 5264458 - Antithrombotic iso- and heterocyclic phenylsulphonamides (1993-11-23),
4. 5191092 - Antithrombotic iso- and heterocyclic phenylsulphonamides (1993-03-02),
5. 5096897 - Antithrombotic substituted cycloalkano(b)dihydroindole- and (1992-03-17),
6. 5079258 - Tetrahydro-1-benz-(C,D)-indolepropionic acid sulphonamides as (1992-01-07),
7. 5039670 - Antithrombotic substituted cycloalkano(B)dihydroindole- and (1991-08-13),
8. 5015657 - 2-halogen-substituted N-indolylethyl-sulphonamides and inhibiting (1991-05-14),
9. 4988820 - Cycloalkano(1,2-B) indole-sulponamides (1991-01-29),
10. 4965258 - Cycloalkano(1,2-B)indole-sulphonamides, pharmaceutical compositions and (1990-10-23),
11. 4921998 - Substituted amino-5,6,7,8-tetrahydronaphthyl-oxyacetic acids, processes (1990-05-01),
12. 4904797 - Process of preparing cycloalkano(1,2-B)indole-sulphonamides (1990-02-27),
13. 4886898 - Intermediates for circulation-active substituted (1989-12-12),
14. 4882353 - Chroman derivatives for combating thrombosis and asthma (1989-11-21),
15. 4868332 - Circulation-active novel substituted (1989-09-19),

Title: **Volker-Bernd Fiedler: A Pioneer in Antithrombotic Innovations**

Introduction

Volker-Bernd Fiedler, an accomplished inventor based in Leverkusen, Germany, has made significant contributions to the field of pharmacology through his innovative inventions. With a remarkable portfolio of 21 patents, his work primarily focuses on the development of antithrombotic agents that address critical health issues.

Latest Patents

Fiedler's latest patents include the invention of natural substance cyclamenol and its chemical derivatives, as well as antithrombotic substituted cycloalkano (B) dihydroindole sulphonamides. These compounds are designed to treat thromboses, thromboembolisms, ischaemias, asthma, and allergies. The patented formula allows for diverse applications due to the variability of hydrogen and other radicals represented by R¹, R², R³, and R⁴.

Career Highlights

As a key researcher at Bayer Aktiengesellschaft, Fiedler has demonstrated a commitment to advancing medical science and improving patient outcomes. His extensive work in developing novel therapeutic agents showcases his dedication to innovation in the pharmaceutical industry. His inventions not only highlight his technical expertise but also address pressing medical needs.

Collaborations

Fiedler has collaborated with esteemed colleagues, including Elisabeth Perzborn and Ulrich Rosentreter, to further enhance the breadth and applicability of his research. These partnerships have been instrumental in translating scientific ideas into practical solutions that can benefit patients worldwide.

Conclusion

Volker-Bernd Fiedler's contributions to the field of antithrombotic research exemplify the impact that dedicated inventors can have on modern medicine. His innovative patents and collaborative efforts continue to pave the way for future advancements in healthcare, making him a notable figure in the world of pharmacological inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…